Overview

The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy of Chinese medicine treatment for chronic atrophic gastritis. It is a multi-center, randomized, placebo-controlled trial.
Phase:
N/A
Details
Lead Sponsor:
Wangjing Hospital, China Academy of Chinese Medical Sciences
Collaborators:
Beijing Hospital of Traditional Chinese Medicine
Beijing University of Chinese Medicine
First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Gansu Provincial Hospital
Guangdong Provincial Hospital of Traditional Chinese Medicine
Hebei Hospital of Traditional Chinese Medicine
Liaoning Hospital of TCM
Shaanxi Hospital of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Shanxi Hospital of Traditional Chinese Medicine
Shanxi Province hospital Research Institute of Traditional Chinese Medicine
ShenZhen AiUYi Health Management Co.,Ltd
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin Nankai Hospital
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine
Treatments:
Hydrotalcite